-
-
In this issue: Individualization of therapy with pharmacogenetics; the rate vs rhythm debate; the FDA's Risk Evaluation and Mitigation Strategy; FDA actions.
-
Pasteurization, the process of heating milk for a predetermined time and maintaining it at a set temperature, has become the cornerstone of milk and dairy product safety.
-
In this study, a total of 358 hospital staff members from 5 hospitals in Melbourne, Australia had both a tuberculin skin test (TST) and a QuantiFERON-TB Gold In-Tube test (QFT-in tube test) performed, and the results were compared.
-
If President Barack Obama's FY2010 budget does send millions of dollars to HIV/AIDS treatment and prevention programs, the money will arrive none too soon, HIV clinicians and researchers say.
-
Even with flat-funding, increased patient loads, and a chronic disease that continues to be complex to treat, HIV providers could manage well enough if it weren't for the unfunded burden of bureaucratic paperwork and rules, some say.
-
At least in the short-term, higher adherence can lead to higher direct health care costs in treating HIV patients, researchers reveal.
-
The only existing female-initiated and controlled HIV prevention method, female condoms can reduce the risk of HIV transmission by some 90%.
-
On Jan. 29, 2009, the Food and Drug Administration (FDA) granted traditional approval for raltegravir (Isentress) 400 mg tablets in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients.
-
